These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15219872)

  • 61. The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target?
    Huang C; Fu XH; Zhou D; Li JM
    Neurochem Res; 2015 Jul; 40(7):1319-32. PubMed ID: 26012365
    [TBL] [Abstract][Full Text] [Related]  

  • 62. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.
    Kuechler A; Willemsen MH; Albrecht B; Bacino CA; Bartholomew DW; van Bokhoven H; van den Boogaard MJ; Bramswig N; Büttner C; Cremer K; Czeschik JC; Engels H; van Gassen K; Graf E; van Haelst M; He W; Hogue JS; Kempers M; Koolen D; Monroe G; de Munnik S; Pastore M; Reis A; Reuter MS; Tegay DH; Veltman J; Visser G; van Hasselt P; Smeets EE; Vissers L; Wieland T; Wissink W; Yntema H; Zink AM; Strom TM; Lüdecke HJ; Kleefstra T; Wieczorek D
    Hum Genet; 2015 Jan; 134(1):97-109. PubMed ID: 25326669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.
    Tucci V; Kleefstra T; Hardy A; Heise I; Maggi S; Willemsen MH; Hilton H; Esapa C; Simon M; Buenavista MT; McGuffin LJ; Vizor L; Dodero L; Tsaftaris S; Romero R; Nillesen WN; Vissers LE; Kempers MJ; Vulto-van Silfhout AT; Iqbal Z; Orlando M; Maccione A; Lassi G; Farisello P; Contestabile A; Tinarelli F; Nieus T; Raimondi A; Greco B; Cantatore D; Gasparini L; Berdondini L; Bifone A; Gozzi A; Wells S; Nolan PM
    J Clin Invest; 2014 Apr; 124(4):1468-82. PubMed ID: 24614104
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neural crest-derived mesenchymal cells require Wnt signaling for their development and drive invagination of the telencephalic midline.
    Choe Y; Zarbalis KS; Pleasure SJ
    PLoS One; 2014; 9(2):e86025. PubMed ID: 24516524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Multilocus loss of DNA methylation in individuals with mutations in the histone H3 lysine 4 demethylase KDM5C.
    Grafodatskaya D; Chung BH; Butcher DT; Turinsky AL; Goodman SJ; Choufani S; Chen YA; Lou Y; Zhao C; Rajendram R; Abidi FE; Skinner C; Stavropoulos J; Bondy CA; Hamilton J; Wodak S; Scherer SW; Schwartz CE; Weksberg R
    BMC Med Genomics; 2013 Jan; 6():1. PubMed ID: 23356856
    [TBL] [Abstract][Full Text] [Related]  

  • 66. GSK3 and β-catenin determines functional expression of sodium channels at the axon initial segment.
    Tapia M; Del Puerto A; Puime A; Sánchez-Ponce D; Fronzaroli-Molinieres L; Pallas-Bazarra N; Carlier E; Giraud P; Debanne D; Wandosell F; Garrido JJ
    Cell Mol Life Sci; 2013 Jan; 70(1):105-20. PubMed ID: 22763697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out.
    Yokoi F; Dang MT; Li Y
    Behav Brain Res; 2012 May; 230(2):389-98. PubMed ID: 22391119
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Zhou T; Li Y
    Hum Mol Genet; 2012 Feb; 21(4):916-25. PubMed ID: 22080833
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Yang G; Li J; Doroodchi A; Zhou T; Li Y
    Behav Brain Res; 2012 Feb; 227(1):12-20. PubMed ID: 22040906
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice.
    Yokoi F; Dang MT; Li J; Standaert DG; Li Y
    PLoS One; 2011; 6(9):e24539. PubMed ID: 21931745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Altered dendritic morphology of Purkinje cells in Dyt1 ΔGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice.
    Zhang L; Yokoi F; Jin YH; DeAndrade MP; Hashimoto K; Standaert DG; Li Y
    PLoS One; 2011 Mar; 6(3):e18357. PubMed ID: 21479250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice.
    Grigoryan T; Wend P; Klaus A; Birchmeier W
    Genes Dev; 2008 Sep; 22(17):2308-41. PubMed ID: 18765787
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene-targeting technologies for the study of neurological disorders.
    Beglopoulos V; Shen J
    Neuromolecular Med; 2004; 6(1):13-30. PubMed ID: 15781974
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
    Bhatia N; Spiegelman VS
    Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
    Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
    Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. beta-catenin and its regulatory network.
    Klymkowsky MW
    Hum Pathol; 2005 Mar; 36(3):225-7. PubMed ID: 15791565
    [No Abstract]   [Full Text] [Related]  

  • 77. Increased seizure susceptibility and cortical malformation in beta-catenin mutant mice.
    Campos VE; Du M; Li Y
    Biochem Biophys Res Commun; 2004 Jul; 320(2):606-14. PubMed ID: 15219872
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
    Hill TP; Später D; Taketo MM; Birchmeier W; Hartmann C
    Dev Cell; 2005 May; 8(5):727-38. PubMed ID: 15866163
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.